Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -98.04% | -46.67% | -- | -- | 134.24% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 0.00% | 0.00% | 0.00% | -6.42% | 4.92% |
Prepaid Expenses | -13.15% | -18.51% | 12.60% | 21.12% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -10.22% | -10.20% | -44.37% | -79.49% | 64.93% |
|
|||||
Total Current Assets | -10.22% | -10.20% | -44.37% | -79.49% | 64.93% |
Net Property, Plant & Equipment | -16.76% | -28.03% | 14.94% | 168.33% | 203.37% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -14.64% | -24.41% | 2.48% | 12.70% | 139.88% |
|
|||||
Total Accounts Payable | 69.96% | 10.19% | 91.62% | 362.28% | 203.46% |
Total Accrued Expenses | 114.69% | 141.72% | 172.87% | 144.76% | 112.04% |
Short-term Debt | -71.34% | 24.44% | 138.68% | 338.24% | 883.95% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3,207.12% | 32.27% | 34.38% | -- | -- |
Total Finance Division Other Current Liabilities | -86.60% | -82.52% | -49.40% | -18.12% | -- |
Total Other Current Liabilities | -86.60% | -82.52% | -49.40% | -18.12% | -- |
Total Current Liabilities | -8.95% | -12.91% | 62.65% | 139.80% | 941.93% |
|
|||||
Total Current Liabilities | -8.95% | -12.91% | 62.65% | 139.80% | 941.93% |
Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Short-term Debt | -71.34% | 24.44% | 138.68% | 338.24% | 883.95% |
Capital Leases | -29.72% | -27.76% | -26.01% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -10.01% | -13.51% | 50.66% | 144.74% | 767.66% |
|
|||||
Common Stock & APIC | 1.59% | 1.70% | 0.47% | 1.85% | 1.33% |
Retained Earnings | 0.59% | -0.23% | -21.06% | -41.86% | -50.79% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | 6.17% | 3.53% | -127.35% | -1,748.50% | -836.22% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.17% | 3.53% | -127.35% | -1,748.50% | -836.22% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.17% | 3.53% | -127.35% | -1,748.50% | -836.22% |
|